Detalhe da pesquisa
1.
Suboptimal dosing of rituximab in male and female patients with DLBCL.
Blood
; 123(5): 640-6, 2014 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-24297867
2.
Enlargement of umbilical incision in standard laparoscopic cholecystectomy is frequently necessary: An argument for the single incision approach?
Minim Invasive Ther Allied Technol
; 24(3): 175-80, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25400218
3.
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.
JAMA
; 307(22): 2390-9, 2012 Jun 13.
Artigo
Inglês
| MEDLINE | ID: mdl-22692171
4.
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Lancet Oncol
; 12(11): 1013-22, 2011 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21940214
5.
Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
N Engl J Med
; 358(2): 125-39, 2008 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-18184958
6.
Ischemic colitis: clinical presentation, localization in relation to risk factors, and long-term results.
World J Surg
; 35(11): 2549-54, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-21882031
7.
Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma.
Br J Haematol
; 166(4): 612-5, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24689462
8.
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
Lancet Oncol
; 9(5): 435-44, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18400558
9.
Gene polymorphisms in the heme degradation pathway and outcome of severe human sepsis.
Shock
; 38(5): 459-65, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23042203
10.
Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use?
Wien Klin Wochenschr
; 123(5-6): 145-55, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21359642
11.
Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.
J Clin Oncol
; 28(14): 2373-80, 2010 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-20385988
12.
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.
Lancet Oncol
; 7(5): 379-91, 2006 May.
Artigo
Inglês
| MEDLINE | ID: mdl-16648042